IBDEI0AK ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14031,2)
 ;;=^73521
 ;;^UTILITY(U,$J,358.3,14032,0)
 ;;=163.9^^92^824^26
 ;;^UTILITY(U,$J,358.3,14032,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14032,1,4,0)
 ;;=4^CA Pleural Cavity
 ;;^UTILITY(U,$J,358.3,14032,1,5,0)
 ;;=5^163.9
 ;;^UTILITY(U,$J,358.3,14032,2)
 ;;=^267140
 ;;^UTILITY(U,$J,358.3,14033,0)
 ;;=171.9^^92^824^51
 ;;^UTILITY(U,$J,358.3,14033,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14033,1,4,0)
 ;;=4^Soft Tissue Sarcoma
 ;;^UTILITY(U,$J,358.3,14033,1,5,0)
 ;;=5^171.9
 ;;^UTILITY(U,$J,358.3,14033,2)
 ;;=^267165
 ;;^UTILITY(U,$J,358.3,14034,0)
 ;;=172.9^^92^824^46
 ;;^UTILITY(U,$J,358.3,14034,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14034,1,4,0)
 ;;=4^Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,14034,1,5,0)
 ;;=5^172.9
 ;;^UTILITY(U,$J,358.3,14034,2)
 ;;=^75462
 ;;^UTILITY(U,$J,358.3,14035,0)
 ;;=174.9^^92^824^12
 ;;^UTILITY(U,$J,358.3,14035,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14035,1,4,0)
 ;;=4^CA Breast
 ;;^UTILITY(U,$J,358.3,14035,1,5,0)
 ;;=5^174.9
 ;;^UTILITY(U,$J,358.3,14035,2)
 ;;=^267202
 ;;^UTILITY(U,$J,358.3,14036,0)
 ;;=176.9^^92^824^41
 ;;^UTILITY(U,$J,358.3,14036,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14036,1,4,0)
 ;;=4^Kaposi's Sarcoma
 ;;^UTILITY(U,$J,358.3,14036,1,5,0)
 ;;=5^176.9
 ;;^UTILITY(U,$J,358.3,14036,2)
 ;;=^107993
 ;;^UTILITY(U,$J,358.3,14037,0)
 ;;=185.^^92^824^27
 ;;^UTILITY(U,$J,358.3,14037,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14037,1,4,0)
 ;;=4^CA Prostate
 ;;^UTILITY(U,$J,358.3,14037,1,5,0)
 ;;=5^185.
 ;;^UTILITY(U,$J,358.3,14037,2)
 ;;=^99481
 ;;^UTILITY(U,$J,358.3,14038,0)
 ;;=186.9^^92^824^33
 ;;^UTILITY(U,$J,358.3,14038,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14038,1,4,0)
 ;;=4^CA Testis
 ;;^UTILITY(U,$J,358.3,14038,1,5,0)
 ;;=5^186.9
 ;;^UTILITY(U,$J,358.3,14038,2)
 ;;=^267242
 ;;^UTILITY(U,$J,358.3,14039,0)
 ;;=188.9^^92^824^9
 ;;^UTILITY(U,$J,358.3,14039,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14039,1,4,0)
 ;;=4^CA Bladder
 ;;^UTILITY(U,$J,358.3,14039,1,5,0)
 ;;=5^188.9
 ;;^UTILITY(U,$J,358.3,14039,2)
 ;;=^267253
 ;;^UTILITY(U,$J,358.3,14040,0)
 ;;=189.0^^92^824^18
 ;;^UTILITY(U,$J,358.3,14040,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14040,1,4,0)
 ;;=4^CA Kidney
 ;;^UTILITY(U,$J,358.3,14040,1,5,0)
 ;;=5^189.0
 ;;^UTILITY(U,$J,358.3,14040,2)
 ;;=^73523
 ;;^UTILITY(U,$J,358.3,14041,0)
 ;;=189.1^^92^824^29
 ;;^UTILITY(U,$J,358.3,14041,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14041,1,4,0)
 ;;=4^CA Renal Pelvis
 ;;^UTILITY(U,$J,358.3,14041,1,5,0)
 ;;=5^189.1
 ;;^UTILITY(U,$J,358.3,14041,2)
 ;;=^267264
 ;;^UTILITY(U,$J,358.3,14042,0)
 ;;=191.9^^92^824^11
 ;;^UTILITY(U,$J,358.3,14042,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14042,1,4,0)
 ;;=4^CA Brain
 ;;^UTILITY(U,$J,358.3,14042,1,5,0)
 ;;=5^191.9
 ;;^UTILITY(U,$J,358.3,14042,2)
 ;;=^267279
 ;;^UTILITY(U,$J,358.3,14043,0)
 ;;=200.10^^92^824^44
 ;;^UTILITY(U,$J,358.3,14043,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14043,1,4,0)
 ;;=4^Lymphoma,Int or High Grade,Uns
 ;;^UTILITY(U,$J,358.3,14043,1,5,0)
 ;;=5^200.10
 ;;^UTILITY(U,$J,358.3,14043,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,14044,0)
 ;;=200.20^^92^824^43
 ;;^UTILITY(U,$J,358.3,14044,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14044,1,4,0)
 ;;=4^Lymphoma,Burkitt's,Unspec
 ;;^UTILITY(U,$J,358.3,14044,1,5,0)
 ;;=5^200.20
 ;;^UTILITY(U,$J,358.3,14044,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,14045,0)
 ;;=201.90^^92^824^40
 ;;^UTILITY(U,$J,358.3,14045,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14045,1,4,0)
 ;;=4^Hodgkin's Lymphoma,Unspec Type
 ;;^UTILITY(U,$J,358.3,14045,1,5,0)
 ;;=5^201.90
 ;;^UTILITY(U,$J,358.3,14045,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,14046,0)
 ;;=202.00^^92^824^45
 ;;^UTILITY(U,$J,358.3,14046,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14046,1,4,0)
 ;;=4^Lymphoma,Low-Grade,Unspec Site
 ;;^UTILITY(U,$J,358.3,14046,1,5,0)
 ;;=5^202.00
 ;;^UTILITY(U,$J,358.3,14046,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,14047,0)
 ;;=202.40^^92^824^39
 ;;^UTILITY(U,$J,358.3,14047,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14047,1,4,0)
 ;;=4^Hairy Cell Leukemia,Unspec
 ;;^UTILITY(U,$J,358.3,14047,1,5,0)
 ;;=5^202.40
 ;;^UTILITY(U,$J,358.3,14047,2)
 ;;=^69587
 ;;^UTILITY(U,$J,358.3,14048,0)
 ;;=203.00^^92^824^48
 ;;^UTILITY(U,$J,358.3,14048,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14048,1,4,0)
 ;;=4^Multiple Myeloma w/o Rem
 ;;^UTILITY(U,$J,358.3,14048,1,5,0)
 ;;=5^203.00
 ;;^UTILITY(U,$J,358.3,14048,2)
 ;;=^336847
 ;;^UTILITY(U,$J,358.3,14049,0)
 ;;=203.01^^92^824^47
 ;;^UTILITY(U,$J,358.3,14049,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14049,1,4,0)
 ;;=4^Multiple Myeloma in Rem
 ;;^UTILITY(U,$J,358.3,14049,1,5,0)
 ;;=5^203.01
 ;;^UTILITY(U,$J,358.3,14049,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,14050,0)
 ;;=204.00^^92^824^2
 ;;^UTILITY(U,$J,358.3,14050,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14050,1,4,0)
 ;;=4^ALL w/o Remission
 ;;^UTILITY(U,$J,358.3,14050,1,5,0)
 ;;=5^204.00
 ;;^UTILITY(U,$J,358.3,14050,2)
 ;;=^336850
 ;;^UTILITY(U,$J,358.3,14051,0)
 ;;=204.01^^92^824^1
 ;;^UTILITY(U,$J,358.3,14051,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14051,1,4,0)
 ;;=4^ALL in Remission
 ;;^UTILITY(U,$J,358.3,14051,1,5,0)
 ;;=5^204.01
 ;;^UTILITY(U,$J,358.3,14051,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,14052,0)
 ;;=204.10^^92^824^36
 ;;^UTILITY(U,$J,358.3,14052,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14052,1,4,0)
 ;;=4^CLL w/o Remission
 ;;^UTILITY(U,$J,358.3,14052,1,5,0)
 ;;=5^204.10
 ;;^UTILITY(U,$J,358.3,14052,2)
 ;;=^336851
 ;;^UTILITY(U,$J,358.3,14053,0)
 ;;=204.11^^92^824^35
 ;;^UTILITY(U,$J,358.3,14053,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14053,1,4,0)
 ;;=4^CLL in Remission
 ;;^UTILITY(U,$J,358.3,14053,1,5,0)
 ;;=5^204.11
 ;;^UTILITY(U,$J,358.3,14053,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,14054,0)
 ;;=205.00^^92^824^3
 ;;^UTILITY(U,$J,358.3,14054,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14054,1,4,0)
 ;;=4^AMI w/o Remission
 ;;^UTILITY(U,$J,358.3,14054,1,5,0)
 ;;=5^205.00
 ;;^UTILITY(U,$J,358.3,14054,2)
 ;;=^336855
 ;;^UTILITY(U,$J,358.3,14055,0)
 ;;=205.01^^92^824^4
 ;;^UTILITY(U,$J,358.3,14055,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14055,1,4,0)
 ;;=4^AML in Remission
 ;;^UTILITY(U,$J,358.3,14055,1,5,0)
 ;;=5^205.01
 ;;^UTILITY(U,$J,358.3,14055,2)
 ;;=^267532
 ;;^UTILITY(U,$J,358.3,14056,0)
 ;;=205.10^^92^824^38
 ;;^UTILITY(U,$J,358.3,14056,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14056,1,4,0)
 ;;=4^CML w/o Remission
 ;;^UTILITY(U,$J,358.3,14056,1,5,0)
 ;;=5^205.10
 ;;^UTILITY(U,$J,358.3,14056,2)
 ;;=^336856
 ;;^UTILITY(U,$J,358.3,14057,0)
 ;;=205.11^^92^824^37
 ;;^UTILITY(U,$J,358.3,14057,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14057,1,4,0)
 ;;=4^CML in Remission
 ;;^UTILITY(U,$J,358.3,14057,1,5,0)
 ;;=5^205.11
 ;;^UTILITY(U,$J,358.3,14057,2)
 ;;=^267534
 ;;^UTILITY(U,$J,358.3,14058,0)
 ;;=232.9^^92^824^30
 ;;^UTILITY(U,$J,358.3,14058,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14058,1,4,0)
 ;;=4^CA Skin in Situ (Bowen's)
 ;;^UTILITY(U,$J,358.3,14058,1,5,0)
 ;;=5^232.9
 ;;^UTILITY(U,$J,358.3,14058,2)
 ;;=^267724
 ;;^UTILITY(U,$J,358.3,14059,0)
 ;;=233.0^^92^824^13
 ;;^UTILITY(U,$J,358.3,14059,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14059,1,4,0)
 ;;=4^CA Breast in Situ
 ;;^UTILITY(U,$J,358.3,14059,1,5,0)
 ;;=5^233.0
 ;;^UTILITY(U,$J,358.3,14059,2)
 ;;=^267735
 ;;^UTILITY(U,$J,358.3,14060,0)
 ;;=233.1^^92^824^14
 ;;^UTILITY(U,$J,358.3,14060,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14060,1,4,0)
 ;;=4^CA Cervical in Situ
 ;;^UTILITY(U,$J,358.3,14060,1,5,0)
 ;;=5^233.1
 ;;^UTILITY(U,$J,358.3,14060,2)
 ;;=^267736
 ;;^UTILITY(U,$J,358.3,14061,0)
 ;;=233.7^^92^824^10
 ;;^UTILITY(U,$J,358.3,14061,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14061,1,4,0)
 ;;=4^CA Bladder in Situ
 ;;^UTILITY(U,$J,358.3,14061,1,5,0)
 ;;=5^233.7
 ;;^UTILITY(U,$J,358.3,14061,2)
 ;;=^267742
 ;;^UTILITY(U,$J,358.3,14062,0)
 ;;=238.4^^92^824^50
 ;;^UTILITY(U,$J,358.3,14062,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14062,1,4,0)
 ;;=4^Polycytheria Rubra Vera
 ;;^UTILITY(U,$J,358.3,14062,1,5,0)
 ;;=5^238.4
 ;;^UTILITY(U,$J,358.3,14062,2)
 ;;=^304816
 ;;^UTILITY(U,$J,358.3,14063,0)
 ;;=238.6^^92^824^49
 ;;^UTILITY(U,$J,358.3,14063,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14063,1,4,0)
 ;;=4^Plasmacytoma NOS
 ;;^UTILITY(U,$J,358.3,14063,1,5,0)
 ;;=5^238.6
 ;;^UTILITY(U,$J,358.3,14063,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,14064,0)
 ;;=238.79^^92^824^42
 ;;^UTILITY(U,$J,358.3,14064,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14064,1,4,0)
 ;;=4^Lymph/Hematpoitc Tis NEC
 ;;^UTILITY(U,$J,358.3,14064,1,5,0)
 ;;=5^238.79
 ;;^UTILITY(U,$J,358.3,14064,2)
 ;;=^334033
 ;;^UTILITY(U,$J,358.3,14065,0)
 ;;=011.90^^92^825^74
 ;;^UTILITY(U,$J,358.3,14065,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14065,1,4,0)
 ;;=4^Tuberculosis
 ;;^UTILITY(U,$J,358.3,14065,1,5,0)
 ;;=5^011.90
 ;;^UTILITY(U,$J,358.3,14065,2)
 ;;=^122756
 ;;^UTILITY(U,$J,358.3,14066,0)
 ;;=031.0^^92^825^44
 ;;^UTILITY(U,$J,358.3,14066,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14066,1,4,0)
 ;;=4^Mycobacteria,Atyp,Pulmonary
 ;;^UTILITY(U,$J,358.3,14066,1,5,0)
 ;;=5^031.0
 ;;^UTILITY(U,$J,358.3,14066,2)
 ;;=^101018
 ;;^UTILITY(U,$J,358.3,14067,0)
 ;;=041.00^^92^825^67
 ;;^UTILITY(U,$J,358.3,14067,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14067,1,4,0)
 ;;=4^Streptococcus,Unspec
 ;;^UTILITY(U,$J,358.3,14067,1,5,0)
 ;;=5^041.00
 ;;^UTILITY(U,$J,358.3,14067,2)
 ;;=^293973
 ;;^UTILITY(U,$J,358.3,14068,0)
 ;;=041.01^^92^825^62
 ;;^UTILITY(U,$J,358.3,14068,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14068,1,4,0)
 ;;=4^Streptococcus,Group A
 ;;^UTILITY(U,$J,358.3,14068,1,5,0)
 ;;=5^041.01
 ;;^UTILITY(U,$J,358.3,14068,2)
 ;;=^293974
 ;;^UTILITY(U,$J,358.3,14069,0)
 ;;=041.02^^92^825^63
 ;;^UTILITY(U,$J,358.3,14069,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14069,1,4,0)
 ;;=4^Streptococcus,Group B
 ;;^UTILITY(U,$J,358.3,14069,1,5,0)
 ;;=5^041.02
